⚡ Interrogation des APIs scientifiques en cours…
⚡ Interrogation des APIs scientifiques en cours…
Authors' conclusion
Does not affect the score
Publi-Score
Fidelity
Abstract (PubMed)
Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials.
Coeff. authors = avg(1.00, 0.85) = 0.93
Coeff. editorial = avg(0.90, 0.90) = 0.90
min(0.93, 0.90) = 0.90← lowest dominates
Alert signal : eoc → Coefficient forced to 0.3
Expression of Concern published
Alert signal : eoc → Coefficient forced to 0.3
Expression of Concern published
Alert signal : eoc → Coefficient forced to 0.3
Expression of Concern published
Final coefficient : 0.30
Final score = 44/52.8 × 0.30 × 100 = 25/100
Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
Hill A — 2021 · Open Forum Infectious Diseases
Contrasted resultsEffect of Early Treatment with Ivermectin among Patients with Covid-19
Reis G — 2022 · New England Journal of Medicine
Contrasted resultsPhysical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T — 2023 · The Cochrane database of systematic reviews
Contrasted resultsAssociation Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring …
Azzolini E — 2022 · JAMA
Contrasted resultsAdverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A …
Amanzio M — 2022 · Lancet Reg Health Eur